Document Detail


Future directions for clinical investigation in thrombolytic therapy.
MedLine Citation:
PMID:  6345024     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Experiments in animals have shown that coronary artery reperfusion limits the extent of myocardial damage and brings about late return of regional contraction and overall left ventricular function over a period of several weeks. Such studies provide a basis for optimism that similar effects can be demonstrated after thrombolytic treatment in man, and such functional contractile recovery should provide an important end point in clinical investigations. However, before the initiation of a large-scale clinical trial, adequate methods for determining salvage of myocardium must be identified, and since changes in such measures may be small, the use of mortality as an end point should also be considered. In addition, the possibility of having two treatment groups to compare intracoronary and intravenous modes of therapy should be examined. Based on the growing number of uncontrolled clinical reports concerned with the success of intracoronary thrombolysis in restoring vessel patency and preliminary data on morbidity, mortality and potential improvement in left ventricular function with this procedure, planning for a randomized clinical trial sponsored by the National Institutes of Health is warranted.
Authors:
J Ross
Related Documents :
9772414 - Multicenter clinical trial of thrombolytic therapy in 1,406 patients with acute myocard...
11774774 - Dominant right ventricular infarction: is angioplasty the optimal therapeutic approach?
10551684 - Overcoming thrombolytic resistance: rationale and initial clinical experience combining...
1806764 - Strategies for administration of tissue plasminogen activator.
9277514 - Disparate effects of preconditioning and mla on 5'-nt and adenosine levels during coron...
10715254 - Aspirin use is low among united states outpatients with coronary artery disease.
Publication Detail:
Type:  Case Reports; Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Circulation     Volume:  68     ISSN:  0009-7322     ISO Abbreviation:  Circulation     Publication Date:  1983 Aug 
Date Detail:
Created Date:  1983-08-26     Completed Date:  1983-08-26     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0147763     Medline TA:  Circulation     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  I105-9     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Cardiomyopathies / etiology
Clinical Trials as Topic
Coronary Artery Bypass
Dogs
Humans
Myocardial Contraction
Myocardial Infarction / complications,  drug therapy,  physiopathology,  therapy*
Random Allocation
Research
Streptokinase / therapeutic use
Grant Support
ID/Acronym/Agency:
HL 17682/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
EC 3.4.-/Streptokinase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Late exercise test results from a prospective randomized study of bypass surgery for stable angina.
Next Document:  Immunochemical quantitation of isoenzymes of aspartate aminotransferase and lactate dehydrogenase.